From: Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial
Group
Total cost
Eradication rates
CER
ITT
V1
57.46
84.4%
0.68
V2
60.58
0.72
V3
70.27
0.83
PP
88.4%
0.65
92.7%
0.79